These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6765528)

  • 21. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.
    Larkins RG; Zajac J; Saunders R; Read A; Hopper JL
    Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipocyte insulin binding and insulin sensitivity in 'brittle' diabetes.
    Taylor R; Husband DJ; Marshall SM; Tunbridge WM; Alberti KG
    Diabetologia; 1984 Oct; 27(4):441-6. PubMed ID: 6391987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and allergenic potential of animal and human insulins.
    Schernthaner G
    Diabetes Care; 1993 Dec; 16 Suppl 3():155-65. PubMed ID: 8299472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of biosynthetic human insulin. Humoral immune response in diabetic patients beginning insulin treatment and in patients previously treated with other insulins.
    Di Mario U; Arduini P; Tiberti C; Lombardi G; Pietravalle P; Andreani D
    Diabetes Res Clin Pract; 1986; 2(6):317-24. PubMed ID: 3545723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin.
    Davidson JK; Fineberg SE; De Meyts P; Fineberg NS; Galloway JA
    Diabetes Care; 1992 May; 15(5):702-4. PubMed ID: 1516491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin binding to erythrocytes in insulin dependent diabetics with different insulin requirement and insulin antibody titre.
    Turco GL; Bruni B; Brossa C; D'Alberto M; Grassi G; Gamba Ansaldi S; Censon A
    J Nucl Med Allied Sci; 1984; 28(3):149-55. PubMed ID: 6397582
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 30. Binding of biosynthetic human insulin to human antibodies and receptors.
    Petersen KG; Schlüter K; Steinhilber S; Kerp L
    Diabetes Care; 1981; 4(2):248-9. PubMed ID: 7011737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes.
    Boden G; Fujita-Yamaguchi Y; Shimoyama R; Shelmet JJ; Tappy L; Rezvani I; Owen OE
    J Clin Invest; 1988 Jun; 81(6):1971-8. PubMed ID: 2968369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA).
    Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ
    Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects: comparison with pork and human pancreatic insulin.
    Bachmann W; Sieger C; Lacher F; Lotz N
    Diabetes Care; 1981; 4(2):215-9. PubMed ID: 7011730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of highly purified Iletin-II-type porcine insulins and human insulin preparations in clinical practice].
    Petunina NA; Balabolkin MI; Mkrtumian AM; Sergeev AV; Nedosugova LV
    Ter Arkh; 1993; 65(10):29-31. PubMed ID: 8296229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extreme insulin resistance: a consequence of insulin switching?
    Keenan WF; Abgott MA
    J Fam Pract; 1988 Dec; 27(6):635-6. PubMed ID: 3058859
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus.
    Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH
    Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The insulin receptor function of mononuclear leukocytes in pregnant women with diabetes mellitus].
    Mikaelian NP; Kniazev IuA; Bespalova VA; Kirbasova NP; Petrukhin VA
    Probl Endokrinol (Mosk); 1990; 36(2):28-31. PubMed ID: 2194201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.
    Hirai H; Ogata E; Kikuchi N; Kohno T; Machii N; Hasegawa K; Watanabe T; Satoh H
    J Med Case Rep; 2016 Jul; 10():202. PubMed ID: 27456688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin.
    Oak S; Phan TH; Gilliam LK; Hirsch IB; Hampe CS
    Acta Diabetol; 2010 Jun; 47(2):131-5. PubMed ID: 19547910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement.
    McEvoy RC; Witt ME; Ginsberg-Fellner F; Rubinstein P
    Diabetes; 1986 Jun; 35(6):634-41. PubMed ID: 3519320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.